Table 1.
Demographic and clinical characteristics of the study sample
IL 6 | CRP | |||||||
---|---|---|---|---|---|---|---|---|
SZ | HC | Statistic | Sig | SZ | HC | Statistic | Sig | |
Mean age±SD (years) | 26.39±8.57 | 25.44±5.50 | t=0.46 | 0.64 | 26.49±8.21 | 26.68±6.41 | t=0.10 | 0.92 |
Sex | ||||||||
Male | 18 | 7 | χ2=3.19 | 0.074 | 21 | 9 | χ2=3.44 | 0.064 |
Female | 15 | 16 | 16 | 18 | ||||
Immune marker levels | 1.14±2.66 ng/ml | 0.96±2.17 ng/ml | t=0.27 | 0.79 | 19.78±23.53 μg/ml | 15.69±21.69 μg/ml | t=0.71 | 0.48 |
Duration of illness | 3.17±2.42 years | ----- | ----- | ----- | 3.12±2.40 years | ----- | ----- | ----- |
BPRS positive symptoms | 8.79±3.80 | ----- | ----- | ----- | 8.93±3.88 | ----- | ----- | ----- |
BPRS negative symptoms | 8.33±3.40 | ----- | ----- | ----- | 8.22±3.33 | ----- | ----- | ----- |